Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003311672 | SCV004010419 | pathogenic | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | TSC2: PVS1, PM2 |
Labcorp Genetics |
RCV005089397 | SCV005839116 | pathogenic | Tuberous sclerosis 2 | 2024-02-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys253*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with tuberous sclerosis complex (PMID: 11112665). ClinVar contains an entry for this variant (Variation ID: 49914). For these reasons, this variant has been classified as Pathogenic. |
Tuberous sclerosis database |
RCV000043181 | SCV000066981 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |